Kenya - English - Pharmacy and Poisons Board

doxorubicin hcl 10mg injection - injection - 10mg doxorubicin hcl 50mg injection - doxorubicin

Canada - English - Health Canada

panda pharmaceuticals inc. - doxorubicin hydrochloride - powder for solution - 50mg - doxorubicin hydrochloride 50mg - antineoplastic agents

Canada - English - Health Canada

strides pharma canada inc - doxorubicin hydrochloride - solution - 2mg - doxorubicin hydrochloride 2mg - antineoplastic agents

Canada - English - Health Canada

pfizer canada ulc - doxorubicin hydrochloride - powder for solution - 10mg - doxorubicin hydrochloride 10mg - antineoplastic agents

Canada - English - Health Canada

pfizer canada ulc - doxorubicin hydrochloride - powder for solution - 50mg - doxorubicin hydrochloride 50mg - antineoplastic agents

Canada - English - Health Canada

pfizer canada ulc - doxorubicin hydrochloride - powder for solution - 150mg - doxorubicin hydrochloride 150mg - antineoplastic agents

Canada - English - Health Canada

accord healthcare inc - doxorubicin hydrochloride - solution - 2mg - doxorubicin hydrochloride 2mg - antineoplastic agents

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

dr. reddy`s laboratories malaysia sdn. bhd. - doxorubicin hydrochloride -

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - doxorubicin hydrochloride -

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - doxorubicin hydrochloride 10mg - powder for injection - 10 mg - active: doxorubicin hydrochloride 10mg excipient: lactose monohydrate - doxorubicin has produced significant therapeutic responses in a number of solid tumours and haematologic malignancies, and is commonly used in the treatment of the following tumours: · carcinoma of the breast · carcinoma of the lung · carcinoma of the ovary · transitional bladder cell cancer · neuroblastoma · wilms' tumour · soft tissue sarcomas · osteosarcoma · acute lymphocytic - lymphoblastic leukaemia · acute myelogenous leukaemia · non-hodgkin's lymphoma · hodgkin's disease doxorubicin has also shown antitumour activity in the following adult and paediatric malignancies: · carcinoma of the thyroid · carcinoma of the endometrium · carcinoma of the head and neck · carcinoma of the stomach · primary hepatocellular carcinoma · non-seminomatous carcinoma of the testis · carcinoma of the prostate · ewing's sarcoma · rhabdomyosarcoma · multiple myeloma · chronic leukaemias